Kalofonos Isabel
Insider CIK 1975163 · CRNX Chief Commercial Officer · CGON Chief Commercial Officer · IMGN SVP & CHIEF COMMERCIAL OFFICER
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGON CG Oncology, Inc. | A Award deriv | 2026-10-15 | 2026-10-19 | 92,000 | — | $0 | 92,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 55,000 | $41.21 | $2.27M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 97,500 | $44.41 | $4.33M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 1,669 | $85.00 | $141.9K | 34,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 34,000 | $85.00 | $2.89M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 55,000 | $41.21 | $2.27M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 97,500 | $44.41 | $4.33M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 34,000 | $85.00 | $2.89M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 1,669 | $85.00 | $141.9K | 34,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-02-23 | 2026-02-25 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-02-23 | 2026-02-25 | 34,000 | — | $0 | 34,834 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-01-05 | 2026-01-07 | 2,500 | — | $0 | 97,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-01-05 | 2026-01-07 | 2,500 | $55.00 | $137.5K | 834 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-01-05 | 2026-01-07 | 2,500 | $40.59 | $101.5K | 3,334 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-01-10 | 2025-01-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 47,375 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,458 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 284,250 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 19,458 | — | $0 | 19,458 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-04-28 | 2023-05-02 | 47,375 | — | $0 | 47,375 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-04-28 | 2023-05-02 | 284,250 | — | $0 | 284,250 | SEC↗ |